Our finding of a lower risk of CV death or HF hospitalization and of a lower risk of HF hospitalization in patients with obesity might suggest a role of GLP-1 RA on hard outcomes in patients with obesity and HF across the EF. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.